Goldman is betting Nvidia will get a boost from health care as industry builds out AI capabilities

Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.
Stocktwits on MSN

Nvidia’s expanding role in AI-driven drug discovery, clinical research could fuel growth, says Goldman Sachs

Goldman Sachs says rising demand for advanced computing power in specialized industries continues to strengthen Nvidia’s ...
Michigan Technological University

Michigan Tech Experts Model the Future of Data Science

Data science is everywhere, a driving force behind modern decisions. When a streaming service suggests a movie, a bank sends ...